HOW IT WORKS

The Colon AiQ screening test detects colorectal cancer in its early stages when it is still curable. It also can detect precancerous lesions (e.g. advanced adenomas) in asymptomatic patients that need endoscopic removal. It is the most accurate, non-invasive test in Europe for colon cancer, based on molecular analysis of blood.

self test vs Colon AiQ
self test vs Colon AiQ

HOW IT WORKS

The Colon AiQ screening test detects colorectal cancer in its early stages when it is still curable. It also can detect precancerous lesions (e.g. advanced adenomas) in asymptomatic patients that need endoscopic removal. It is the most accurate, non-invasive test in Europe for colon cancer, based on molecular analysis of blood.

The self-test (FIT – fecal immunochemical test) is a method of detecting tiny traces of blood in the stool. However, it only detects the presence of blood.

In contrast, Colon AiQ is an innovative, non-invasive test that uses genetic analysis of blood samples to detect specific changes at the DNA level associated with the presence of colorectal cancer.

Colon AiQ vs. self test (FIT)

Colon AiQ Fecal self-test (FIT)
A molecular test which analyses biomarkers of methylation in blood and is performed in an authorized molecular biology laboratory with experienced scientific staff. Simple detection of blood in stool
Can detect polyps and adenomas in any form Cannot detect polyps and adenomas if there is no bleeding in the intestine
Achieves high sensitivity in early stages of cancer I & II Comparatively shows limited sensitivity in early stages of cancer I & II

Colon AiQ vs. self test (FIT)

Colon AiQ
A molecular test which analyses biomarkers of methylation in blood and is performed in an authorized molecular biology laboratory with experienced scientific staff.
Can detect polyps and adenomas in any form
Achieves high sensitivity in early stages of cancer I & II
Fecal self-test (FIT)
Simple detection of blood in stool
Cannot detect polyps and adenomas if there is no bleeding in the intestine
Comparatively shows limited sensitivity in early stages of cancer I & II

The self-test (FIT – fecal immunochemical test) is a method of detecting tiny traces of blood in the stool. However, it only detects the presence of blood.

In contrast, Colon AiQ is an innovative, non-invasive test that uses genetic analysis of blood samples to detect specific changes at the DNA level associated with the presence of colorectal cancer.

καρκίνος παχέος εντέρου

COLON CANCER

Colorectal cancer is the third most common cancer worldwide after breast and lung cancer and the second most common in terms of deaths. Prevention and early diagnosis are crucial in the treatment of colorectal cancer.

καρκίνος παχέος εντέρου

COLON CANCER

Colorectal cancer is the third most common cancer worldwide after breast and lung cancer and the second most common in terms of deaths. Prevention and early diagnosis are crucial in the treatment of colorectal cancer.